Skip to main content
. 2016 Oct 1;7(47):76667–76683. doi: 10.18632/oncotarget.12395

Table 1. Sequences of RNAi oligonucleotides used in the present study.

Name Sequence 5′→3′
si-MAVS UAGUUGAUCUCGCGGACGA-dTdT (sense)
UCGUCCGCGAGAUCAACUA-dTdT (antisense)
control mimic UUCUCCGAACGUGUCACGUTT (sense)
ACGUGACACGUUCGGAGAATT (antisense)
miR-22 mimic AAGCUGCCAGUUGAAGAACUGU (sense)
AGUUCUUCAACUGGCAGCUUUU (antisense)
control inhibitor CAGUACUUUUGUGUAGUACAA
miR-22 inhibitor ACAGUUCUUCAACUGGCAGCUU